Phase 1 Study of BMS-986416 with and without Nivolumab in Solid Tumors

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-501317-31-00

Acronym

CA102-003

Enrollment

Registered

2023-06-13

Start date

2023-06-29

Completion date

2024-05-31

Last updated

2024-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid tumor

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026